Követés
Yuen-Yi (Moony) Tseng
Yuen-Yi (Moony) Tseng
Broad Institute of MIT and Havard
E-mail megerősítve itt: broadinstitute.org
Cím
Hivatkozott rá
Hivatkozott rá
Év
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
VS Viswanathan, MJ Ryan, HD Dhruv, S Gill, OM Eichhoff, ...
Nature 547 (7664), 453-457, 2017
13332017
Organoid modeling of the tumor immune microenvironment
JT Neal, X Li, J Zhu, V Giangarra, CL Grzeskowiak, J Ju, IH Liu, SH Chiou, ...
Cell 175 (7), 1972-1988. e16, 2018
10202018
PVT1 dependence in cancer with MYC copy-number increase
YY Tseng, BS Moriarity, W Gong, R Akiyama, A Tiwari, H Kawakami, ...
Nature 512 (7512), 82-86, 2014
7422014
Patient-derived xenografts undergo mouse-specific tumor evolution
U Ben-David, G Ha, YY Tseng, NF Greenwald, C Oh, J Shih, ...
Nature genetics 49 (11), 1567-1575, 2017
6812017
A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis
Y Zou, MJ Palte, AA Deik, H Li, JK Eaton, W Wang, YY Tseng, R Deasy, ...
Nature communications 10 (1), 1617, 2019
5522019
Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood
J Joung, JM Engreitz, S Konermann, OO Abudayyeh, VK Verdine, F Aguet, ...
Nature 548 (7667), 343-346, 2017
3982017
WRN helicase is a synthetic lethal target in microsatellite unstable cancers
EM Chan, T Shibue, JM McFarland, B Gaeta, M Ghandi, N Dumont, ...
Nature 568 (7753), 551-556, 2019
2712019
Assessment of heavy metal bioavailability in contaminated sediments and soils using green fluorescent protein-based bacterial biosensors
VHC Liao, MT Chien, YY Tseng, KL Ou
Environmental pollution 142 (1), 17-23, 2006
1392006
Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development
K Giannikou, IA Malinowska, TJ Pugh, R Yan, YY Tseng, C Oh, J Kim, ...
PLoS genetics 12 (8), e1006242, 2016
1062016
The PVT1-MYC duet in cancer
YY Tseng, A Bagchi
Molecular & Cellular Oncology 2 (2), e974467, 2015
742015
A combination CDK4/6 and IGF1R inhibitor strategy for Ewing sarcoma
LM Guenther, NV Dharia, L Ross, A Conway, AL Robichaud, JL Catlett, ...
Clinical Cancer Research 25 (4), 1343-1357, 2019
732019
Activation of endothelial cells to pathological status by down-regulation of connexin43
HH Wang, CI Kung, YY Tseng, YC Lin, CH Chen, CH Tsai, HI Yeh
Cardiovascular research 79 (3), 509-518, 2008
702008
Integrated genetic and pharmacologic interrogation of rare cancers
AL Hong, YY Tseng, GS Cowley, O Jonas, JH Cheah, BD Kynnap, ...
Nature communications 7 (1), 11987, 2016
522016
CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity
J Joung, PC Kirchgatterer, A Singh, JH Cho, SP Nety, RC Larson, ...
Nature Communications 13 (1), 1606, 2022
462022
Caenorhabditis elegans expresses a functional ArsA
YY Tseng, CW Yu, VHC Liao
The FEBS Journal 274 (10), 2566-2572, 2007
392007
Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition
AL Hong, YY Tseng, JA Wala, WJ Kim, BD Kynnap, MB Doshi, G Kugener, ...
Elife 8, e44161, 2019
382019
MYC and PVT1 synergize to regulate RSPO1 levels in breast cancer
AL Sarver, CD Murray, NA Temiz, YY Tseng, A Bagchi
Cell cycle 15 (7), 881-885, 2016
322016
From cell lines to living biosensors: new opportunities to prioritize cancer dependencies using ex vivo tumor cultures
YY Tseng, JS Boehm
Current Opinion in Genetics & Development 54, 33-40, 2019
212019
HIF-2α drives an intrinsic vulnerability to ferroptosis in clear cell renal cell carcinoma
Y Zou, MJ Palte, AA Deik, H Li, JK Eaton, W Wang, YY Tseng, R Deasy, ...
BioRxiv, 388041, 2018
102018
MP99-18 role of long non-coding RNA PVT1 in regulating MYC in human cancer
K Tashiro, YY Tseng, B Konety, A Bagchi
The Journal of Urology 197 (4S), e1327-e1328, 2017
52017
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20